Lamotrigine
Product Images NDC 50090-2814

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 50090-2814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 01)

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 01)
Chemical structure of lamotrigine, showing a triazine ring linked to a dichlorophenyl group and amine substituents, consistent with the active ingredient lamotrigine by A-S Medication Solutions.*
FDA Label Image

Lamotrigine Tablet (C76106cb 5861 428c B91e C0f3c0a92472 02)

Lamotrigine Tablet (C76106cb 5861 428c B91e C0f3c0a92472 02)
A line chart showing failure probability (%) plotted over weeks for Lamotrigine versus placebo. The graph includes labeled curves for both Lamotrigine and placebo groups, with censored data points marked. The failure probability increases over time for both groups, with placebo generally showing higher failure probability compared to Lamotrigine.*
FDA Label Image

Lamotrigine Tablets (C76106cb 5861 428c B91e C0f3c0a92472 03)

Lamotrigine Tablets (C76106cb 5861 428c B91e C0f3c0a92472 03)
A Kaplan-Meier survival curve chart comparing failure probability (%) over weeks between Lamotrigine and Placebo groups. The graph shows failure probability increasing over time with separate lines for Lamotrigine and Placebo, including censored data points marked with crosses. The x-axis represents weeks (0 to 80), and the y-axis shows failure probability percentage (0 to 100).*
FDA Label Image

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 04)

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 04)
A data table showing Lamotrigine tablet descriptions by strength from 25 mg to 250 mg. Each entry details tablet color as white to off-white and the specific debossing on each side of the bisected tablet, including "ZC" combined with unique numbers corresponding to each strength (e.g., 79 for 25 mg, 90 for 50 mg, up to 91 for 250 mg).*
FDA Label Image

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 05)

Structured Formula For Lamotrigine (C76106cb 5861 428c B91e C0f3c0a92472 05)
An illustration depicting two tablet imprints for Lamotrigine by A-S Medication Solutions. One tablet is 5 mg, white to off-white, bisected and debossed with 'Z' on one side and '13' on the other side. The other tablet is 25 mg, white to off-white, debossed with 'Z' and '12' on one side.*
FDA Label Image

Label Image (Lbl500902814)

Label Image (Lbl500902814)
Lamotrigine 100 mg tablets label from A-S Medication Solutions, NDC 50090-28114-0. The label includes storage instructions at 68 to 77°F in a dry place and indicates a bottle count of 32 unit dose tablets. It also shows dosage preparation details and distribution information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.